載入...
Eribulin mesylate in the treatment of metastatic breast cancer
The treatment of metastatic breast cancer (MBC) has become increasingly challenging as the primary goals of therapy include prolonging life without added toxicity. While multiple agents are approved for the therapy of MBC, there is no standard approach for therapy beyond the second-line. Eribulin me...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3266863/ https://ncbi.nlm.nih.gov/pubmed/22291464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S19811 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|